Diagnosis and management of a patient with chronic subjective tinnitus is one of the most labour-intensive areas of hearing healthcare. This is one reason some hearing care providers opt to exclude specialised tinnitus care from their practice: it may not...
I was enormously grateful for the chance to articulate my personal thoughts on ‘the industry interaction with the ENT clinical community’. To set a context, the term ‘industry’ refers to medical technology manufacturers and suppliers, in addition to pharmaceutical companies....
Founded in 2007, Denmark’s Ida Institute is dedicated to the health of people with hearing loss. Its new four-part course, however, is aimed at another group: the medical professionals whose jobs can compromise their own health.
The British Acoustic Neuroma Association (BANA) will host their Annual Conference this year in Ashover in the Peak District, this year focusing on members’ personal experiences. BANA (British Acoustic Neuroma Association) is a registered charity providing invaluable information and support to people with Acoustic Neuroma / Vestibular Schwannoma (ANVS) and their support networks.
“This is not, I repeat, not, a marketing textbook.” A strange, if somewhat bemusing opening to a book with the word ‘Marketing’ firmly placed in its title. The author then goes on to explain why it is not a marketing...
It is considerable sadness that we have to report the death of Lawrie Cleary. Lawrie Cleary played a major part in the history of cochlear implantation in the UK. He had lifelong hearing loss and was a patient of mine...
Cytophil, Inc. is pleased to announce the expansion of the exclusive distribution agreement with Soluvos Medical BV for Cytophil’s ENT products for all European countries, including United Kingdom, plus Dutch territories, South Africa and India.
The William Demant Foundation has announced plans to donate DKK 8 million ($1.2 million USD) to support humanitarian aid in and outside Ukraine to meet the growing needs of children and families, including those on the move.
Neuromod Devices has announced the formation of a global commercial leadership team to further commercialise its Lenire tinnitus treatment device through key partnerships.